Immunoglobulin E-mediated airway inflammation is active in most patients with asthma

Journal of the American Academy of Nurse Practitioners

Volumn 19, Issue 9, 2007, Pages 439-449

  Hayden, Mary Lou ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Virginia Adult and Pediatric Allergy and Asthma

Author keywords

Asthma; Asthma control; IgE; Omalizumab; Treatment guidelines

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; OMALIZUMAB;

ADULT; ARTICLE; ASTHMA; CASE REPORT; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; MAST CELL; METHODOLOGY; NURSE PRACTITIONER; PATIENT SELECTION; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; RISK FACTOR;

ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; MAST CELLS; NURSE PRACTITIONERS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34548261711     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2007.00251.x     Document Type: Article

References (74)

1. Adcock, I. M., Lane, S. J., Brown, C. R., Peters, M. J., Lee, T. H. Barnes, P. J. (1995). Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. Journal of Immunology, 154, 3500 3505.
2. Allen-Ramey, F., Schoenwetter, W. F., Weiss, T. W., Westerman, D., Majid, N. Markson, L. E. (2005). Sensitization to common allergens in adults with asthma. Journal of the American Board of Family Practice, 18, 434 439.
3. American Lung Association Epidemiology & Statistics Unit 2005). Trends in asthma morbidity and mortality. Retrieved July 22, 2007, from http://www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA-4604-8ADE-7F5D5E762256%7D/ ASTHMA1.PDF
4. Baroody, F., deTineo, M., Haney, L., Clark, K., Blair, C. Naclerio, R 2000). Influx of eosinophils into the maxillary sinus after nasal challenge with allergen [Abstract]. Journal of Allergy and Clinical Immunology, 105 (Suppl S70 S71.
5. Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J., Pauwels, R. A., et al 2004). Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. American Journal of Respiratory and Critical Care Medicine, 170, 836 844.
6. Bender, B. G. Bender, S. E. (2005). Patient-identified barriers to asthma treatment adherence: Responses to interviews, focus groups, and questionnaires. Immunology and Allergy Clinics of North America, 25, 107 130.
7. Berger, W. E., Schenkel, E. J. Mansfield, L. E. (2002). Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Annals of Allergy, Asthma and Immunology, 89, 485 491.
8. Borish, L., Chipps, B., Deniz, Y., Gujrathi, S., Zheng, B. Dolan, C. M. (2005). Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Annals of Allergy, Asthma and Immunology, 95, 247 253.
9. Bousquet, J., Vignola, A. M. Demoly, P 2003). Links between rhinitis and asthma. Allergy, 58, 691 706.
10. Buhl, R., Hanf, G., Soler, M., Bensch, G., Wolfe, J., Everhard, F., et al 2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. European Respiratory Journal, 20, 1088 1094.
11. Buhl, R., Soler, M., Matz, J., Townley, R., O'Brien, J., Noga, O., et al 2002). Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. European Respiratory Journal, 20, 73 78.
12. Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A. Cline, M. G. (1989). Association of asthma with serum IgE levels and skin-test reactivity to allergens. New England Journal of Medicine, 320, 271 277.
13. Busse, W. Kraft, M 2005). Cysteinyl leukotrienes in allergic inflammation: Strategic target for therapy. Chest, 127, 1312 1326.
14. Busse, W. W. (2001). Anti-immunoglobulin E (omalizumab) therapy in allergic asthma. American Journal of Respiratory and Critical Care Medicine, 164, S12 S117.
15. Carranza Rosenzweig, J. R., Edwards, L., Lincourt, W., Dorinsky, P. ZuWallack, R. L. (2004). The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respiratory Medicine, 98, 1157 1165.
16. Chan, M. T., Leung, D. Y., Szefler, S. J. Spahn, J. D. (1998). Difficult-to-control asthma: Clinical characteristics of steroid-insensitive asthma. Journal of Allergy and Clinical Immunology, 101, 594 601.
17. Cho, Y. J. Lee, K. E. (2003). Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma. Allergy and Asthma Proceedings, 24, 353 358.
18. Cochrane, M. G., Bala, M. V., Downs, K. E., Mauskopf, J. Ben-Joseph, R. H. (2000). Inhaled corticosteroids for asthma therapy: Patient compliance, devices, and inhalation technique. Chest, 117, 542 550.
19. Corren, J., Adinoff, A. D., Buchmeier, A. D. Irvin, C. G. (1992). Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. Journal of Allergy and Clinical Immunology, 90, 250 256.
20. Corren, J., Diaz-Sanchez, D., Saxon, A., Deniz, Y., Reimann, J., Sinclair, D., et al 2004). Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Annals of Allergy, Asthma and Immunology, 93, 243 248.
21. Corren, J., Harris, A. G., Aaronson, D., Beaucher, W., Berkowitz, R., Bronsky, E., et al 1997). Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. Journal of Allergy and Clinical Immunology, 100, 781 788.
22. Corren, J., Manning, B. E., Thompson, S. F., Hennessy, S. Strom, B. L. (2004). Rhinitis therapy and the prevention of hospital care for asthma: A case-control study. Journal of Allergy and Clinical Immunology, 113, 415 419.
23. ®), a recombinant humanized monoclonal anti-IgE antibody. Clinical Reviews in Allergy and Immunology, 29 (1 31 48.
24. Durham, S. R. (1999). Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy, 54 (Suppl. 57 124 131.
25. Finn, A., Gross, G., van Bavel, J., Lee, T., Windom, H., Everhard, F., et al 2003). Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. Journal of Allergy and Clinical Immunology, 111, 278 284.
26. Foresi, A., Pelucchi, A., Gherson, G., Mastropasqua, B., Chiapparino, A. Testi, R 1996). Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. Journal of Allergy and Clinical Immunology, 98, 274 282.
27. Fox, J. A., Hotaling, T. E., Struble, C., Ruppel, J., Bates, D. J. Schoenhoff, M. B. (1996). Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys. Journal of Pharmacology and Experimental Therapeutics, 279, 1000 1008.
28. Freidhoff, L. R. Marsh, D. G. (1993). Relationship among asthma, serum IgE levels and skin test sensitivity to inhaled allergens. International Achieves of Allergy and Immunology, 100, 355 361.
29. Global Initiative for Asthma 2005). Global Strategy for Asthma Management and Prevention (NIH Publication No. 02-3659). Bethesda, MD : National Heart, Lung and Blood Institute. National Institutes of Health.
30. Grant, J. A., Nicodemus, C. F., Findlay, S. R., Glovsky, M. M., Grossman, J., Kaiser, H., et al 1995). Cetirizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology, 95, 923 932.
31. Greisner, W. A., III., Settipane, R. J. Settipane, G. A. (1998). Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy and Asthma Proceedings, 19 (4 185 188.
32. Guerra, S., Sherrill, D. L., Martinez, F. D. Barbee, R. A. (2002). Rhinitis as an independent risk factor for adult-onset asthma. Journal of Allergy and Clinical Immunology, 109, 419 425.
33. 2-adrenergic receptor agonists in adult chronic asthmatics. Allergology International, 53, 291 299.
34. Holgate, S. T., Chuchalin, A. G., Hebert, J., Lotvall, J., Persson, G. B., Chung, K. F., et al 2004). Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clinical and Experimental Allergy, 34, 632 638.
35. Holt, S., Suder, A., Weatherall, M., Cheng, S., Shirtcliffe, P. Beasley, R 2001). Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: Meta-analysis. BMJ, 323, 253 256.
36. Israel, E., Drazen, J. M., Liggett, S. B., Boushey, H. A., Cherniack, R. M., Chinchilli, V. M., et al 2000). The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. American Journal of Respiratory and Critical Care Medicine, 162, 75 80.
37. Jonasson, G., Carlsen, K. H., Sodal, A., Jonasson, C. Mowinckel, P 1999). Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. European Respiratory Journal, 14, 150 154.
38. Juniper, E. F., Wisniewski, M. E., Cox, F. M., Emmett, A. H., Nielsen, K. E. O'Byrne, P. M. (2004). Relationship between quality of life and clinical status in asthma: A factor analysis. European Respiratory Journal, 23, 287 291.
39. Kerkhof, M., Dubois, A. E., Postma, D. S., Schouten, J. P. de Monchy, J. G. (2003). Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy, 58, 905 911.
40. Klink, M., Cline, M. G., Halonen, M. Burrows, B 1990). Problems in defining normal limits for serum IgE. Journal of Allergy and Clinical Immunology, 85, 440 444.
41. Klinnert, M. D., Nelson, H. S., Price, M. R., Adinoff, A. D., Leung, D. Y. Mrazek, D. A. (2001). Onset and persistence of childhood asthma: Predictors from infancy. Pediatrics, 108 (4 E69.
42. Lanier, B. Q. (2003). Newer aspects in the treatment of pediatric and adult asthma. Monoclonal anti-IgE. Annals of Allergy, Asthma and Immunology, 90 (6, Suppl. 3 13 15.
43. Lantz, C. S., Yamaguchi, M., Oettgen, H. C., Katona, I. M., Miyajima, I., Kinet, J. P., et al 1997). IgE regulates mouse basophil Fc epsilon RI expression in vivo. Journal of Immunology, 158, 2517 2521.
44. Lee, D. K., Jackson, C. M., Bates, C. E. Lipworth, B. J. (2004). Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Thorax, 59, 662 667.
45. Leung, D. Y. Bloom, J. W. (2003). Update on glucocorticoid action and resistance. Journal of Allergy and Clinical Immunology, 111, 3 22 quiz 23.
46. Loke, T. K., Sousa, A. R., Corrigan, C. J. Lee, T. H. (2002). Glucocorticoid-resistant asthma. Current Allergy and Asthma Reports, 2 (2 144 150.
47. Mannino, D. M., Homa, D. M., Akinbami, L. J., Moorman, J. E., Gwynn, C. Redd, S. C. (2002). Surveillance for asthma-United States, 1980-1999. Morbidity and Mortality Weekly Report. Surveillance Summaries, 51, 1 13.
48. Masoli, M., Weatherall, M., Holt, S. Beasley, R 2004). Clinical dose-response relationship of fluticasone propionate in adults with asthma. Thorax, 59 (1 16 20.
49. Matthews, J. G., Ito, K., Barnes, P. J. Adcock, I. M. (2004). Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. Journal of Allergy and Clinical Immunology, 113, 1100 1108.
50. McGeehan, M. Busse, W. W. (2002). Refractory asthma. Medical Clinics of North America, 86, 1073 1090.
51. Milgrom, H., Berger, W., Nayak, A., Gupta, N., Pollard, S., McAlary, M., et al 2001). Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics, 108 (2 E36.
52. National Asthma Education and Prevention Program 1997). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma (No. 02-5075). Bethesda, MD : National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI).
53. National Asthma Education and Prevention Program 2003). Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Bethesda, MD : National Heart, Lung, and Blood Institute. National Institutes of Health.
54. Oettgen, H. C. Geha, R. S. (1999). IgE in asthma and atopy: Cellular and molecular connections. Journal of Clinical Investigation, 104, 829 835.
55. Ong, Y., Menzies-Gow, A., Barkans, J., Benyahia, F., Ou, T. T., Ying, S. Kay, A. B. (2005). Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge. Journal of Allergy and Clinical Immunology, 116 (3 558 564.
56. Platts-Mills, T. A. (2001). The role of immunoglobulin E in allergy and asthma. American Journal of Respiratory and Critical Care Medicine, 164, S1 S15.
57. Pollart, S. M., Chapman, M. D., Fiocco, G. P., Rose, G. Platts-Mills, T. A. (1989). Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. Journal of Allergy and Clinical Immunology, 83, 875 882.
58. Presta, L., Shields, R., O'Connell, L., Lahr, S., Porter, J., Gorman, C., et al 1994). The binding site on human immunoglobulin E for its high affinity receptor. Journal of Biological Chemistry, 269, 26368 26373.
59. Rabe, K. F., Vermeire, P. A., Soriano, J. B. Maier, W. C. (2000). Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study. European Respiratory Journal, 16, 802 807.
60. Rosenwasser, L. Nash, D 2003). Incorporating omalizumab into asthma treatment guidelines: Consensus panel recommendations. Pharmacy and Therapeutics, 28, 400 414.
61. Salpeter, S. R., Ormiston, T. M. Salpeter, E. E. (2004). Meta-analysis: Respiratory tolerance to regular beta2-agonist use in patients with asthma. Annals of Internal Medicine, 140, 802 813.
62. Sherrill, D. L., Stein, R., Halonen, M., Holberg, C. J., Wright, A. Martinez, F. D. (1999). Total serum IgE and its association with asthma symptoms and allergic sensitization among children. Journal of Allergy and Clinical Immunology, 104, 28 36.
63. Soler, M., Matz, J., Townley, R., Buhl, R., O'Brien, J., Fox, H., et al 2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. European Respiratory Journal, 18, 254 261.
64. Sunyer, J., Anto, J. M., Sabria, J., Roca, J., Morell, F., Rodriguez-Roisin, R., et al 1995). Relationship between serum IgE and airway responsiveness in adults with asthma. Journal of Allergy and Clinical Immunology, 95, 699 706.
65. Szefler, S. J., Martin, R. J., King, T. S., Boushey, H. A., Cherniack, R. M., Chinchilli, V. M., et al 2002). Significant variability in response to inhaled corticosteroids for persistent asthma. Journal of Allergy and Clinical Immunology, 109, 410 418.
66. Tantisira, K. G., Lake, S., Silverman, E. S., Palmer, L. J., Lazarus, R., Silverman, E. K., et al 2004). Corticosteroid pharmacogenetics: Association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Human Molecular Genetics, 13, 1353 1359.
67. Taylor, D. R., Drazen, J. M., Herbison, G. P., Yandava, C. N., Hancox, R. J. Town, G. I. (2000). Asthma exacerbations during long term beta agonist use: Influence of beta(2) adrenoceptor polymorphism. Thorax, 55, 762 767.
68. Togias, A 2004). Systemic effects of local allergic disease. Journal of Allergy and Clinical Immunology, 113 (Suppl S8 S814.
69. Turner, H. Kinet, J. P. (1999). Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature, 402 (Suppl B24 B230.
70. Watson, W. T., Becker, A. B. Simons, F. E. (1993). Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness. Journal of Allergy and Clinical Immunology, 91, 97 101.
71. Weir, T. D., Mallek, N., Sandford, A. J., Bai, T. R., Awadh, N., Fitzgerald, J. M., et al 1998). Beta2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. American Journal of Respiratory and Critical Care Medicine, 158, 787 791.
72. Wittig, H. J., Belloit, J., De Fillippi, I. Royal, G 1980). Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease. Journal of Allergy and Clinical Immunology, 66, 305 313.
73. Wolfenden, L. L., Diette, G. B., Krishnan, J. A., Skinner, E. A., Steinwachs, D. M. Wu, A. W. (2003). Lower physician estimate of underlying asthma severity leads to undertreatment. Achieves of Internal Medicine, 163, 231 236.
74. ® Omalizumab for subcutaneous use [package insert] 2003). South San Francisco, CA : Genentech.